Overview
Mark Kieran is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Kieran is highly rated in 10 conditions, according to our data. His top areas of expertise are Glioma, Brain Stem Cancer, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.
His clinical research consists of co-authoring 177 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- EPO
- HMO
- POS
- PPO
Locations
450 Brookline Ave, Boston, MA 02215
Additional Areas of Focus
Dr. Kieran has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Dana-Farber Cancer Institute
Rachael Grace is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Grace is highly rated in 13 conditions, according to our data. Her top areas of expertise are Pyruvate Kinase Deficiency, Immune Thrombocytopenic Purpura (ITP), Hemolytic Anemia, Splenectomy, and Gallbladder Removal.
Dana-Farber Cancer Institute
Steven Dubois is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Dubois is highly rated in 11 conditions, according to our data. His top areas of expertise are Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.
Dana-Farber Cancer Institute
Matthew Heeney is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Heeney is highly rated in 14 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.
Frequently Asked Questions about Dr. Mark Kieran
How do I make an appointment with Dr. Mark Kieran?
You can book an appointment with Dr. Mark Kieran by calling their office at 617-632-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Kieran a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Kieran is classified as an Distinguished expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Kieran specialize in?
While Dr. Mark Kieran is a Hematology, they have specific expertise in Glioma, Brain Stem Cancer, and Diffuse Midline Glioma H3 K27M-Mutant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mark Kieran participate in research or clinical trials?
Yes. Dr. Mark Kieran has published 177 articles and abstracts on conditions like Glioma. You can view a list of Dr. Mark Kieran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Kieran accept my insurance?
Dr. Mark Kieran accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 617-632-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Brain Stem CancerDr. Kieran isDistinguished. Learn about Brain Stem Cancer.
- Diffuse Midline Glioma H3 K27M-MutantDr. Kieran isDistinguished. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- GliomaDr. Kieran isDistinguished. Learn about Glioma.
- MedulloblastomaDr. Kieran isDistinguished. Learn about Medulloblastoma.
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- NeurofibromatosisDr. Kieran isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Kieran isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- NUT CarcinomaDr. Kieran isAdvanced. Learn about NUT Carcinoma.
- PineocytomaDr. Kieran isAdvanced. Learn about Pineocytoma.
- Rhabdoid TumorDr. Kieran isAdvanced. Learn about Rhabdoid Tumor.
- Experienced
- Adult Soft Tissue SarcomaDr. Kieran isExperienced. Learn about Adult Soft Tissue Sarcoma.
- GangliogliomaDr. Kieran isExperienced. Learn about Ganglioglioma.
- Infantile NeutropeniaDr. Kieran isExperienced. Learn about Infantile Neutropenia.
- Langerhans Cell HistiocytosisDr. Kieran isExperienced. Learn about Langerhans Cell Histiocytosis.
- Malignant Peripheral Nerve Sheath TumorDr. Kieran isExperienced. Learn about Malignant Peripheral Nerve Sheath Tumor.
- NeuroblastomaDr. Kieran isExperienced. Learn about Neuroblastoma.